Cabinet papers:
Allowing sales of cold medicines containing pseudoephedrine
Misuse of Drugs (Pseudoephedrine) Amendment Bill 2024: Approval for Introduction
New Zealand funds their medicine through PHARMAC, a crown entity that determines and negotiates which essential medicine will be funded with their limited budget. The budget, given by the NZ government, was 71 million for 2022 and 120 million for 2023. PHARMAC has...
NZ has a strong research basis to possibly accelerate the drug research and development industry - an industry that is going through rapid changes by outsourcing drug development to different countries.
Consistent with existing literature, we find that the level of frailty is significantly associated with the cost of healthcare. However, we find no association between drug burden and nonpharmaceutical/overall healthcare costs.
Four intermediate health service outcomes were identified: development of extended community pharmacist services; consumers using extended community pharmacist services; more integrated, collaborative primary health care services; and a fit-for-purpose community pharmacy workforce.
The Radiation Safety Act 2016 (the Act) is administered by the Manatū Hauora – the Ministry of Health (the Ministry). Section 86(1) of the Act allows the Director for Radiation Safety (Director) to issue codes of practice. This is for the purpose of specifying technical requirements.
Cabinet material, associated briefing and regulatory impact statement: Improving the Medicinal Cannabis Scheme to better support economic and research opportunities.
Cabinet papers:
Amendments to prescribing regulations for controlled drugs
Misuse of Drugs Amendment Regulations
Proactive release of the Cabinet material relating to the transitioning of labelling requirements for medicines newly scheduled as controlled drugs under the Misuse of Drugs Act 1975.
These documents provide context around the Government's decision to amend the Therapeutic Products Bill to create an exemption regime for small-scale natural health product producers and remove most obligations for rongoā.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI